1. Home
  2. GDOT vs HUMA Comparison

GDOT vs HUMA Comparison

Compare GDOT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDOT
  • HUMA
  • Stock Information
  • Founded
  • GDOT 1999
  • HUMA 2004
  • Country
  • GDOT United States
  • HUMA United States
  • Employees
  • GDOT N/A
  • HUMA N/A
  • Industry
  • GDOT Finance: Consumer Services
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDOT Finance
  • HUMA Health Care
  • Exchange
  • GDOT Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • GDOT 572.3M
  • HUMA 577.7M
  • IPO Year
  • GDOT 2010
  • HUMA N/A
  • Fundamental
  • Price
  • GDOT $8.81
  • HUMA $4.56
  • Analyst Decision
  • GDOT Hold
  • HUMA Strong Buy
  • Analyst Count
  • GDOT 4
  • HUMA 7
  • Target Price
  • GDOT $10.75
  • HUMA $13.43
  • AVG Volume (30 Days)
  • GDOT 537.4K
  • HUMA 8.3M
  • Earning Date
  • GDOT 02-25-2025
  • HUMA 11-08-2024
  • Dividend Yield
  • GDOT N/A
  • HUMA N/A
  • EPS Growth
  • GDOT N/A
  • HUMA N/A
  • EPS
  • GDOT N/A
  • HUMA N/A
  • Revenue
  • GDOT $1,629,683,000.00
  • HUMA N/A
  • Revenue This Year
  • GDOT N/A
  • HUMA N/A
  • Revenue Next Year
  • GDOT $10.91
  • HUMA $5,584.53
  • P/E Ratio
  • GDOT N/A
  • HUMA N/A
  • Revenue Growth
  • GDOT 10.45
  • HUMA N/A
  • 52 Week Low
  • GDOT $7.70
  • HUMA $2.80
  • 52 Week High
  • GDOT $13.58
  • HUMA $9.97
  • Technical
  • Relative Strength Index (RSI)
  • GDOT 27.89
  • HUMA 49.10
  • Support Level
  • GDOT $8.68
  • HUMA $4.30
  • Resistance Level
  • GDOT $9.30
  • HUMA $4.67
  • Average True Range (ATR)
  • GDOT 0.36
  • HUMA 0.37
  • MACD
  • GDOT -0.10
  • HUMA -0.04
  • Stochastic Oscillator
  • GDOT 14.68
  • HUMA 36.99

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Share on Social Networks: